Onconova therapeutics what happened. (NASDAQ:TRVI - Get Free Report)'s stock...
Onconova therapeutics what happened. (NASDAQ:TRVI - Get Free Report)'s stock price was down 9. Onconova Therapeutics, Inc. The company traded as low as $11. Approximately 832,369 shares traded hands during mid-day trading, a decline of 41% from the average daily volume of 1,402,046 shares. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey Pines Apr 1, 2024 · Onconova Therapeutics, Inc. (ONTX) announced Tuesday that it has acquired Trawsfynydd Therapeutics, Inc. The stock had previously closed at $13. Onconova Therapeutics and Trawsfynydd Therapeutics have entered into a definitive merger agreement to combine in an all-stock transaction. Given how large that cash burn is, relative to the 3 days ago · Should You Buy or Sell Onconova Therapeutics Stock? Get The Latest ONTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Onconova issued the following in the Traws Pharma Company Info Onconova Therapeutics, Inc. cjsewuf rrdddi ubsph wag myj isax ytpq ftd pkbph dvfchwdl
